Heart Protection Study
From Wikipedia, the free encyclopedia
The Heart Protection Study was a randomized controlled trial run by the Clinical Trial Service Unit, and funded by the Medical Research Council (MRC) and the British Heart Foundation (BHF) in the United Kingdom. It studied the use of the cholesterol lowering drug, simvastatin 40 mg and vitamin supplementation (vitamin E, vitamin C and beta carotene) in people who were at risk of cardiovascular disease. It was led by Jane Armitage, an epidemiologist at the Clinical Trial Service Unit.[1][2]
Quick Facts Type of project, Country ...
Heart Protection Study | |
---|---|
![]() Simvastatin 3D | |
Type of project | randomized controlled trial |
Country | United Kingdom |
Funding |
|
Status | Completed |
Close